Immunocore Holdings (IMCR) Receivables (2021 - 2025)
Historic Receivables for Immunocore Holdings (IMCR) over the last 5 years, with Q3 2025 value amounting to $75.9 million.
- Immunocore Holdings' Receivables rose 1922.9% to $75.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $75.9 million, marking a year-over-year increase of 1922.9%. This contributed to the annual value of $63.0 million for FY2024, which is 2095.48% up from last year.
- As of Q3 2025, Immunocore Holdings' Receivables stood at $75.9 million, which was up 1922.9% from $69.8 million recorded in Q2 2025.
- Immunocore Holdings' Receivables' 5-year high stood at $75.9 million during Q3 2025, with a 5-year trough of $7.3 million in Q4 2021.
- For the 5-year period, Immunocore Holdings' Receivables averaged around $54.6 million, with its median value being $61.6 million (2024).
- Its Receivables has fluctuated over the past 5 years, first skyrocketed by 35792.2% in 2022, then soared by 925.65% in 2025.
- Quarter analysis of 5 years shows Immunocore Holdings' Receivables stood at $7.3 million in 2021, then skyrocketed by 357.92% to $33.6 million in 2022, then soared by 55.11% to $52.1 million in 2023, then rose by 20.95% to $63.0 million in 2024, then rose by 20.46% to $75.9 million in 2025.
- Its Receivables stands at $75.9 million for Q3 2025, versus $69.8 million for Q2 2025 and $63.1 million for Q1 2025.